Navigation Links
Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients

PHILADELPHIA, Jan. 26 /PRNewswire/ -- Liquent, Inc. today announced Omnicare Clinical Research has licensed LiquentConnect® - a hosted software as a service (SaaS) solution used to quickly and easily create, review, amend and submit regulatory dossiers.  Omnicare Clinical Research is a leading Phase I to IV global contract research organization serving the biopharmaceutical and medical device industries.

LiquentConnect enables organizations to produce their own eCTD and non electronic submissions without investing in IT infrastructure.  All software and hardware upgrades are managed and executed by Liquent.  LiquentConnect is fully executable for eCTD, NeeS and CTD publishing.  

"As portions of the industry shift toward SaaS, we are pleased to offer LiquentConnect, a SaaS solution publishing tool," said Rick Riegel, Liquent's Chief Executive Officer. "Liquent is committed to providing value-add solutions to our customers.  LiquentConnect provides reliable, secure access to your dossiers from anywhere with an internet connection."

Omnicare Clinical Research selected Liquent and will be utilizing LiquentConnect as its hosted solution provider due to Liquent's depth of expertise within the regulatory and life-sciences industry.  The benefits of implementing a fully-managed SaaS solution outweighed the time and resource investment required for other solutions.  

"LiquentConnect provides our organization and our customers with project submission data that is safe and secure.  Liquent provided us with a solution that is not only flexible, but one that we believe can expand to meet our needs and offer an efficient and cost-effective tool to address a variety of situations, from eCTD to NeeS to paper," said Dr. Martine Dehlinger-Kremer, Vice President of Global Regulatory Affairs for Omnicare Clinical Research.  

About Omnicare Clinical Research

Established in 1985, Omnicare Clinical Research is a full-service CRO, with diverse therapeutic expertise and comprehensive clinical service offerings, supporting the pharmaceutical industry throughout every aspect of a clinical project. Furthermore, the Company features specialized expertise in phase I-III clinical services, clinical supplies packaging, labeling, storage and distribution services, and functional service provider relationships from its office locations in over 30 countries worldwide. Omnicare Clinical Research is a subsidiary of Omnicare, Inc. (NYSE: OCR), a leading provider of pharmacy services to long-term care facilities and other chronic care settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada.

About Liquent, Inc.

Liquent regulatory solutions provide software and related regulatory and clinical services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.  For more information please visit,

SOURCE Liquent, Inc.



SOURCE Liquent, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
2. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
3. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
4. Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams Pre-Clinical Development of Neuroprotective Parkinsons Therapies
5. Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
6. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
7. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
8. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
9. Enbrel Will Remain Decision Resources Clinical Gold Standard Through 2018 for the Treatment of Rheumatoid Arthritis
10. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
11. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
Post Your Comments:
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):